Toxogonin, Injektionslösung

7680315140115 CH-31514 Injektionslösung
Toxogonin, Injektionslösung
Toxogonin, Injektionslösung
Toxogonin, Injektionslösung
1 / 3
google

Article details

Package size
5
Selling units
5
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/01/2022
Summary of Product Characteristics
Français
25/01/2022
Summary of Product Characteristics
Italien
25/01/2022

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Curatis AG

4410 Liestal

Authorization information

Swissmedic authorization number
31514
Drug name
Toxogonin, Injektionslösung
Galenic form
LSPA
ATC Code
V03AB13
Authorization status
Z
Dispensing category
B
First authorization
09/06/1965
Authorization expiration date
31/12/9999
IT Number
15.01.0.
Domain
Human medicine
Field of application
Organophosphat-Vergiftungen

Package details

Description (FR)
TOXOGONIN sol inj 250 mg/ml 5 amp 1 ml
Description (DE)
TOXOGONIN Inj Lös 250 mg/ml 5 Amp 1 ml
Market launch
29/01/2009
Narcotic (BTM)
No

Other package sizes (1)

TOXOGONIN sol inj 250 mg/ml 5 amp 1 ml
5 AMP
GTIN: 7680315140108
Not in V1